Results 91 to 100 of about 44,185 (156)

Impact of dupilumab on SNOT-22 domain and individual item scores in chronic rhinosinusitis with nasal polyps. [PDF]

Sci Rep
Lang A, Habenbacher M, Moser U, Pock J, Lampl T, Holzmeister C, Abaira A, Staudinger J, Andrianakis A.   +8 more
europepmc   +1 more source

Navigating challenges in management of difficult-to-treat chronic rhinosinusitis with nasal polyps in the greater Gulf. [PDF]

Saudi Med J
Marglani OA, Razzak Juratli A, Maatouq Alwael A, Hussain Alokby G, Al Rayyes HYA, Alsharif SAA, Abo El Ezz TA.   +6 more
europepmc   +1 more source

Clinical and radiologic findings in angiomatous nasal polyps. [PDF]

Mol Clin Oncol
Yeom S, Lee DH, Lim SC.
europepmc   +1 more source

Safety and efficacy of anti-IL-5 monoclonal antibodies as second-line therapy for chronic rhinosinusitis with nasal polyps: a meta-analysis. [PDF]

Front Immunol
Liao H, Qiu C, Luo Y, Chen J, Qin C, Quan J, Liang W, Qin J, Chen R.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Telomerase in Nasal Polyps

American Journal of Rhinology, 2007
Background The aim of this study was to determine the presence and location of telomerase activities and the possible influence of elevated human telomerase reverse transcriptase (hTERT) mRNA levels on the outcome after surgical treatment in nasal polyposis.
Yue-Shih, Chen, Martin, Westhofen, Johann, Lorenzen   +2 more
openaire   +2 more sources